1. Home
  2. IGC vs CLIR Comparison

IGC vs CLIR Comparison

Compare IGC & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • CLIR
  • Stock Information
  • Founded
  • IGC 2005
  • CLIR 2008
  • Country
  • IGC United States
  • CLIR United States
  • Employees
  • IGC N/A
  • CLIR N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • CLIR Industrial Machinery/Components
  • Sector
  • IGC Health Care
  • CLIR Industrials
  • Exchange
  • IGC Nasdaq
  • CLIR Nasdaq
  • Market Cap
  • IGC 33.5M
  • CLIR 27.9M
  • IPO Year
  • IGC N/A
  • CLIR 2012
  • Fundamental
  • Price
  • IGC $0.37
  • CLIR $0.60
  • Analyst Decision
  • IGC Strong Buy
  • CLIR Strong Buy
  • Analyst Count
  • IGC 2
  • CLIR 1
  • Target Price
  • IGC $3.88
  • CLIR $2.00
  • AVG Volume (30 Days)
  • IGC 7.5M
  • CLIR 78.7K
  • Earning Date
  • IGC 08-07-2025
  • CLIR 08-13-2025
  • Dividend Yield
  • IGC N/A
  • CLIR N/A
  • EPS Growth
  • IGC N/A
  • CLIR N/A
  • EPS
  • IGC N/A
  • CLIR N/A
  • Revenue
  • IGC $1,271,000.00
  • CLIR $2,895,000.00
  • Revenue This Year
  • IGC $15.26
  • CLIR $27.61
  • Revenue Next Year
  • IGC $3.41
  • CLIR $116.19
  • P/E Ratio
  • IGC N/A
  • CLIR N/A
  • Revenue Growth
  • IGC N/A
  • CLIR 10.88
  • 52 Week Low
  • IGC $0.25
  • CLIR $0.46
  • 52 Week High
  • IGC $0.48
  • CLIR $1.72
  • Technical
  • Relative Strength Index (RSI)
  • IGC 54.60
  • CLIR 55.62
  • Support Level
  • IGC $0.30
  • CLIR $0.50
  • Resistance Level
  • IGC $0.46
  • CLIR $0.63
  • Average True Range (ATR)
  • IGC 0.04
  • CLIR 0.05
  • MACD
  • IGC 0.00
  • CLIR 0.01
  • Stochastic Oscillator
  • IGC 33.00
  • CLIR 75.36

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

Share on Social Networks: